OncoTherapy Network Highlights National Blood Cancer Awareness Month

NORWALK, Conn., Sept. 19, 2014 /PRNewswire/ -- UBM Medica US announces that  OncoTherapy Network, a leading online community to help oncologists and other clinicians gain a better understanding of the newest information available regarding the use of targeted therapies and immunotherapies, discusses some of the latest news on blood cancer research and treatment. 

Every September, Blood Cancer Awareness Month is observed as a way to raise awareness about blood cancers—helping to increase survival rates and improve the quality of life for those living with these kinds of cancers.

The featured articles below discuss some of the most recent research findings, along with a breakthrough designation immunotherapy by the FDA :

• Lymphoma Patients Being 'Hit' With Aggressive Disease: With indolent lymphomas, there have been many new advances that provide treatment options for patients who have this type of lymphoma. But, for the patient with aggressive lymphoma that must be treated immediately, treatment options have not advanced as rapidly. 
• Patient-Tailored Immunotherapy Receives Breakthrough Designation From FDA: A personalized immunotherapy called chimeric antigen receptor (CAR) therapy has been given the "breakthrough therapy" designation by the U.S. Food and Drug Administration (FDA). The investigational therapy known as CTL019 is being developed for relapsed and refractory acute lymphoblastic leukemia (ALL) for both adult and pediatric patients.
• Addition of Lenalidomide to R-CHOP May Improve Outcomes in Patients With Non-GCB DLBCL: Addition of the immunomodulatory agent lenalidomide to R-CHOP may reduce the negative prognostic significance of the non-GCB (germinal center B-cell) phenotype in patients with newly diagnosed diffuse large B-cell lymphoma (DLBCL).

About UBM Medica US
Addressing today's healthcare information needs, UBM Medica US, delivers strategic, integrated communications solutions and comprehensive reach -- online, in print, via custom programs and live events. Improving the effectiveness of healthcare through information and education, UBM Medica US provides unbiased clinical, practical, and business information for physicians, providers and payers resulting in improved quality of care for patients around the world. Through journals, magazines, online communities, live and digital events, and other valuable resources, UBM Medica US also delivers comprehensive communication solutions for the pharmaceutical and related industries. Online communities include CancerNetwork.com, ConsultantLive.com, DiagnosticImaging.com, RheumatologyNetwork.com, OBGYN.net, PhysiciansPractice.com, PsychiatricTimes.com and SearchMedica.com. UBM Medica US is part of UBM Americas which, through a range of aligned interactive environments, both physical and digital – increases business effectiveness for both customers and audiences through meaningful experiences, knowledge and connections.  Headquartered in New York, UBM Americas brings together UBM's healthcare business, UBM Medica US; UBM Tech's technology communities, live events and custom services; UBM Canon's advanced design and manufacturing event, online and print brands; UBM Connect New York's catering, cruise shipping, contact-center management, and fine, specialty and custom chemical communities; and UBM Mexico's concrete, construction and hospitality services shows.  For more information, visit www.UBMMedicaUS.com.

About UBM plc

UBM plc is a global events-led marketing services and communications company.  We help businesses do business, bringing the world's buyers and sellers together at events and online, as well as producing and distributing news and specialist content.  Our 5,500 staff in more than 30 countries are organized into expert teams which serve commercial and professional communities, helping them to do business and their markets to work effectively and efficiently.

For more information, go to www.ubm.com; follow us on Twitter at @UBM_plc to get the latest UBM corporate news.

Media contact:
Jason J. Golden
Content Marketing Manager
203-523-7040
[email protected]

SOURCE UBM Medica US

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED